Novel Drug Delivery Systems (NDDS) | Global Market Trajectory & Analytics | Industry Worth $28.1 Billion by 2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Novel Drug Delivery Systems (NDDS) – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Novel Drug Delivery Systems (NDDS) Market to Reach US$28.1 Billion by the Year 2026

Growth in the global market is set to be primarily driven by the benefits offered by controlled-release drug delivery systems, including reduced treatment cost, lower side effects, and enhanced therapeutic efficacy. The growing adoption of controlled-release drugs as a standard treatment for various diseases, rising awareness and demand for advanced products among physicians, and increasing prescription of controlled-release products are some of the key factors that are likely to bolster the market growth in the near future.

Further, presence of several in-vivo biological barriers that impacts the drug’s stability, absorption, and bioavailability are opening lucrative opportunities for the adoption of controlled-release drug delivery systems. The adoption of controlled-release drug delivery systems is also being propelled by the rapidly growing pediatric and geriatric population, owing to high incidence of non-adherence to prescription drugs in these age-groups.

Nanotechnology has come to the fore to further enhance the relevance of continuous improvisation and innovation of NDDS, especially for administering active agents. Several terminal diseases such as immunodeficiency diseases and cancers require controlled and targeted therapy with minimum side effects, and for these systems, nanocarrier-based systems deliver a better therapeutic effect at the target site. Currently, the pharmaceutical industry is preparing for widespread adoption of nanoparticles, which represents a crucial element in advanced nanotechnology-enabled delivery systems.

Amid the COVID-19 crisis, the global market for Novel Drug Delivery Systems (NDDS) estimated at US$9 Billion in the year 2020, is projected to reach a revised size of US$28.1 Billion by 2026, growing at a CAGR of 20.8% over the analysis period. Nanoparticles, one of the segments analyzed in the report, is projected to grow at a 20.3% CAGR to reach US$27.2 Billion by the end of the analysis period.

After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Embolization Particles segment is readjusted to a revised 22.9% CAGR for the next 7-year period. This segment currently accounts for a 17.3% share of the global Novel Drug Delivery Systems (NDDS) market.

The rising uptake of nanotechnology and its various concepts including nanocarriers in novel drug delivery mechanisms is driving growth in the Nanoparticles segment. The use of nanoparticles in delivering drugs to cancer cells with minimum damage to healthy cells is the most promising application of nanotechnology in drug delivery currently under development.

The U.S. Market is Estimated at $4 Billion in 2021, While China is Forecast to Reach $2.9 Billion by 2026

The Novel Drug Delivery Systems (NDDS) market in the U.S. is estimated at US$4 Billion in the year 2021. The country currently accounts for a 37.8% share in the global market. China, the world’s second largest economy, is forecast to reach an estimated market size of US$2.9 Billion in the year 2026 trailing a CAGR of 25.7% through the analysis period.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18% and 19.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 19.5% CAGR while Rest of European market (as defined in the study) will reach US$3.7 Billion by the end of the analysis period.

Select Competitors (Total 238 Featured)

• AstraZeneca PLC
• Boston Scientific Corporation
• Cospheric LLC
• EmboMedics, Inc.
• F. Hoffmann-La Roche AG
• Merit Medical Systems, Inc.
• Mo-Sci Corporation
• Polysciences, Inc.
• Sirtex Medical Inc.
• Terumo Medical Corporation

Key Topics Covered

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Impact of COVID-19 and a Looming Global Recession
• 2020: A Year of Disruption & Transformation
• As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
• An Insight into Pandemic Impact on Pharmaceuticals Industry
• COVID-19 & Other Factors Shift Focus to Different Drug Delivery Approaches
• Novel Drug Delivery Systems Gain Interest Amid the Fight Against COVID-19
• Nanomaterial-enabled Novel Drug Delivery Systems Gain Interest in Vaccine Development
• Novel Drug Delivery System (NDDS): A Prelude
• Versatile Benefits of NDDS Drive Companies to Embrace the Drug Delivery Approach
• Patient Compliance: A Key Reason Garnering Interest in NDD
• Regulatory Process for Novel Drug Delivery Systems
• A Look into Current Areas of Research in Drug Delivery
• Market Outlook
• Nanotechnology-Enabled Drug Delivery: Primary Challenges
• Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Nanotechnology Bolsters Demand for NDDS
• Prospects Remain Encouraging
• Microfluidics Mediated NDDS Set to Make Gains
• Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes
• Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery
• List of Marketed Liposome-Based Clinical Products Classified by Therapeutic Areas
• Liposomes-based Drug Delivery Systems to touch Diverse Areas of Modern Medicine
• Dendrimers as Ideal Drug Delivery Agents
• List of Commercially Available Dendrimeric Products by Application Area
• High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems
• Oral Thin Films Enhance NDDS Domain
• Nanotechnology-Enabled Drug Delivery Opens New Horizons to Improve Cancer Treatments
• Rising Cancer Incidence Drives Focus onto Novel Drug Delivery Mechanisms
• Novel Drug Delivery System Emerges as a Potential Treatment for Pediatric Brain Tumors
• Uptrend in Gene Therapy Market Augurs Well for Market Growth
• Adeno-Associated Virus Vectors: A Leading Platform for Gene Therapy
• Application of Nanotechnology-based Drug Delivery Systems for CVD Treatment
• NDD for Antimicrobial Drugs
• List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use
• Nanotechnology Opens New Avenues in Antiretroviral Therapy
• Demonstrated Activity of Select Nanotechnology-Delivered Antiretroviral Therapies
• Novel Drug Delivery System Exhibits Potential to Target HIV Reservoirs
• Novel Drug Delivery Systems for CNS Therapeutics
• Novel Drug and a New Delivery Method for Restoring Brain Cells in People Suffering from PD
• Nanotechnology Powers Next Wave of Change for Neglected Tropical Diseases’ Treatment
• Novel Drug Delivery Systems Hold Edge over Existing Therapies for Diabetic Retinopathy
• Exciting Immunology Developments Involving Graphene-based Nanomaterials
• Nanotechnology-Based Strategies for siRNA Grows in Popularity
• Nanoemulsions Begin to Make a Mark
• Inorganic Nanocarriers Facilitate High Payload Capacity and Co-Delivery Platforms for MDR Cancer Therapy
• Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery
• Recent Advancements in Polymeric Drug Delivery Systems
• Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest
• Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery
• SLNs in Pulmonary Delivery of Drugs
• Other Nanocarriers in Pulmonary Delivery
• Increasing Importance of Gold Nanoparticles in Targeted Drug Administration
• Gold Nanoparticles Open New Avenues in Combinatorial Cancer Therapy
• Consistent Rise in Healthcare Spending Worldwide to Drive Market Opportunities

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 238

For more information about this report visit https://www.researchandmarkets.com/r/8gxurv

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900